We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.41B
AUM Growth
+$274M
Cap. Flow
+$112M
Cap. Flow %
4.66%
Top 10 Hldgs %
24.57%
Holding
158
New
13
Increased
40
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
DNTH icon
Dianthus Therapeutics
DNTH
+$31.6M
2
TECX
Tectonic Therapeutic
TECX
+$27.9M
3
MYOV
Myovant Sciences Ltd.
MYOV
+$22.5M
4
PANW icon
Palo Alto Networks
PANW
+$20.8M
5
SAGE
Sage Therapeutics
SAGE
+$18.8M

Top Sells

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$52M
2
CAFD
8point3 Energy Partners LP
CAFD
+$18.9M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$18M
4
TWLO icon
Twilio
TWLO
+$12.5M
5
SNA icon
Snap-on
SNA
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 42.26%
2 Technology 16.99%
3 Consumer Discretionary 12.15%
4 Industrials 8.07%
5 Utilities 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHN
151
DELISTED
Athenahealth, Inc.
ATHN
– –
-37,000
Closed -$5.29M
CAFD
152
DELISTED
8point3 Energy Partners LP
CAFD
– –
-1,553,600
Closed -$18.9M
AVXS
153
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-421,000
Closed -$52M
WBK
154
DELISTED
Westpac Banking Corporation
WBK
– –
-40,000
Closed -$887K
3 4 5 6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Eventide Asset Management held 158 positions worth $2.41B, up 13% from $2.14B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management deployed $112M of net new capital in Q2 2018, opening 13 new positions and adding to 40 existing holdings. Its largest new stake was Dianthus Therapeutics: 139,881 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Snap-on, an estimated $10.6M trimmed.

  • Eventide Asset Management's largest Q2 2018 buy was Dianthus Therapeutics: 139,881 shares worth $29.5M.
  • Eventide Asset Management added most to Myovant Sciences Ltd. in Q2 2018, an estimated $22.5M increase.
  • Eventide Asset Management's biggest Q2 2018 reduction was Snap-on, cutting an estimated $10.6M.
  • Eventide Asset Management fully exited AveXis, Inc. Common Stock in Q2 2018, selling an estimated $52M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $2.41B portfolio in Q2 2018.
  • Eventide Asset Management opened 13 new positions and closed 14 in Q2 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.41B.

Based on Eventide Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.